Market Overview:
The global lorazepam tablets market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of anxiety disorders and other psychiatric disorders, rising geriatric population, and growing demand for lorazepam tablets in emerging markets. Based on type, the global lorazepam tablets market is segmented into 0.5mg, 1mg, 2mg, and others. The 1mg segment is expected to account for the largest share of the global market in 2018 owing to its high demand as a treatment for anxiety disorders and other psychiatric conditions. Based on application, the global lorazepam tablets market is segmented into hospitals, clinics, recovery centers (including drug rehabilitation centers), and others (including research institutes). The hospitals segment accounted for the largest share of the global market in 2017 owing to increased use of lorazepam tablets as an adjunctive therapy for various medical conditions such as seizures and status epilepticus.
Product Definition:
Lorazepam tablets are benzodiazepine tranquilizers used to treat anxiety disorders, insomnia, and seizure disorders. Lorazepam is also used as a preoperative medicine to produce calmness and shorten the time it takes to fall asleep.
0.5mg:
0.5mg is a typical dosage for the Lorazepam tablets and has been used as an anti- Anxiety medication for decades. The drug works by binding to benzodiazepine receptors in the brain, which reduces anxiety by enhancing GABA ( Gamma-aminobutyric acid) function.
1mg:
1mg is a low dose and is used for the treatment of insomnia, anxiety, and agoraphobia. Lorazepam tablets are used to treat these conditions by reducing the frequency of your heartbeat and may also cause drowsiness.
The medicine has no major side effects; however, it does not help in treating depression or Alzheimer’s disease as it only works on Anxiety disorders.
Application Insights:
The hospital application segment led the global lorazepam tablets market in 2017. The recovery center segment is expected to witness significant growth over the forecast period owing to increasing cases of anxiety disorders and depression. In addition, growing awareness about mental health issues coupled with rising availability of treatment centers is anticipated to drive demand for lorazepam tablets in recovery centers globally.
The clinics application segment accounted for a share of 21% in 2017 and is projected to grow at a CAGR exceeding 8% from 2018 to 2030 due largelyto its ability as an alternative therapy for panic disorder and agoraphobia without any negative side effects or drug interactions associated with it as compared with benzodiazepines such as diazepam which are extensively used worldwide. Growing adoption of these tablets by primary care physicians dueto their non-toxic nature along with low cost will boost industry growth over the forecast period globally.
Regional Analysis:
North America dominated the global market in 2017 owing to high product demand for anxiety disorder treatment. The region is expected to witness significant growth over the forecast period due to increasing cases of substance abuse and dependency. Rising awareness about mental disorders, supportive government initiatives, and high disposable income are some factors contributing toward market growth in this region.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China & India & Indonesia etc. Furthermore, growing medical tourism industry will also boost product demand over next eight years or so. Increasing incidence of panic attacks and anxiety disorders among young population are also driving regional market expansion efforts from big players such as Johnson & Johnson Consumer Inc.; Actavis LLC; Shire plc; Purdue Pharma Ligand Ltd.; Allergan PLC; Endo Pharmaceuticals Inc.; Eisai Co., Ltd.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for Lorazepam tablets in the coming years.
- Rising prevalence of anxiety disorders: The prevalence of anxiety disorders is on the rise globally and this is expected to boost the demand for Lorazepam tablets in the near future.
- Growing awareness about benefits of Lorazepam tablets: There is growing awareness about the benefits of using Lorazepam tablets among consumers worldwide, which is likely to propel market growth in the coming years.
- Availability of generic versions: The availability of generic versions of Lorazepam tablets at affordable prices has made it more accessible to a larger number of people, thereby propelling market growth over the forecast period. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Lorazepam Tablets Market Research Report
By Type
0.5mg, 1mg, 2mg
By Application
Hospital, Clinics, Recovery Center
By Companies
Bausch Health, Mylan, Aurobindo, Pfizer, Major Pharmaceuticals, Leading Pharma, Sandoz, Teva, Hemofarm, Hunan Dongting Pharmaceutical, Huazhong Yaoye, Shandong Sinepharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Lorazepam Tablets Market Report Segments:
The global Lorazepam Tablets market is segmented on the basis of:
Types
0.5mg, 1mg, 2mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- Mylan
- Aurobindo
- Pfizer
- Major Pharmaceuticals
- Leading Pharma
- Sandoz
- Teva
- Hemofarm
- Hunan Dongting Pharmaceutical
- Huazhong Yaoye
- Shandong Sinepharm
Highlights of The Lorazepam Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.5mg
- 1mg
- 2mg
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lorazepam Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lorazepam tablets are a medication used to treat anxiety and panic disorders. They work by calming the brain and nerves, which can help relieve symptoms such as fear, anxiety, and panic attacks.
Some of the major players in the lorazepam tablets market are Bausch Health, Mylan, Aurobindo, Pfizer, Major Pharmaceuticals, Leading Pharma, Sandoz, Teva, Hemofarm, Hunan Dongting Pharmaceutical, Huazhong Yaoye, Shandong Sinepharm.
The lorazepam tablets market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lorazepam Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lorazepam Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lorazepam Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lorazepam Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lorazepam Tablets Market Size & Forecast, 2020-2028
4.5.1 Lorazepam Tablets Market Size and Y-o-Y Growth
4.5.2 Lorazepam Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 0.5mg
5.2.2 1mg
5.2.3 2mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lorazepam Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lorazepam Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 0.5mg
9.6.2 1mg
9.6.3 2mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 0.5mg
10.6.2 1mg
10.6.3 2mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 0.5mg
11.6.2 1mg
11.6.3 2mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 0.5mg
12.6.2 1mg
12.6.3 2mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 0.5mg
13.6.2 1mg
13.6.3 2mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lorazepam Tablets Market: Competitive Dashboard
14.2 Global Lorazepam Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 Mylan
14.3.3 Aurobindo
14.3.4 Pfizer
14.3.5 Major Pharmaceuticals
14.3.6 Leading Pharma
14.3.7 Sandoz
14.3.8 Teva
14.3.9 Hemofarm
14.3.10 Hunan Dongting Pharmaceutical
14.3.11 Huazhong Yaoye
14.3.12 Shandong Sinepharm
